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Abstract 
 
BACKGROUND. “Expanded” composite materials are of interest as an alternative, or as a 
supplement, to packed-bed chromatography during bioproduct recovery and purification. 
Functionalized non-woven fabrics and mega-porous bodies are examples of systems that 
showed promise. However, there is scarce information on their suitability to capture and 
release plasmid DNA (pDNA), an important type of product employed in gene therapy. 
 
RESULTS. Composite adsorbents were prepared via either chemical (CG-DEAE-NW) or 
gamma-irradiated graft-polymerization (GIR-DEAE-MP), and subsequently modified to have 
diethylamino ethanol (DEAE) functionality. Capture experiments showed that pDNA can 
actually reversibly bind to the two mentioned adsorbents, with capacities values of 2.4 mg 
per mL and 1.3 mg per mL, respectively. These values are in the range of what can be 
expected from commercial beaded adsorbents but lower that the values expected from 
monoliths. 
 
CONCLUSIONS. Expanded materials, due to their high voidage, may present a limited 
capacity for pDNA. However, such materials are able to bind proteins and other contaminants 
from bacterial lysate, opening the way for their utilization in the “negative” mode. 
 
Keywords: pDNA purification; expanded adsorbents; chromatography; gene therapy. 
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Introduction 
 
Liquid chromatography is the most widely used method for the purification of 
therapeutic biomolecules (e.g. pDNAs, mRNA, or VLPs) as it provides high product 
resolution and uses GRAS chemicals. Chromatographic processes can be operated under 
various conditions, where physical and chemical properties of plasmid DNA can play a 
significant role in separations. Several chromatographic methods such as anion exchange 
(AEX)1, size exclusion (SEC)2, hydrophobic interaction (HIC)3, 4 , reversible phase (RPLC)5, 
triple helix , and boronate affinity chromatography6 have been reported for the purification of 
pDNA. Anion exchange chromatography, while being the most commonly used approach for 
purifying biomolecules, are poor at resolving pDNA from other nucleic acids that have 
similar charge density7, 8. In RNase-free bioprocesses, RNA is found to co-elute with pDNA 
as there are no other means of RNA reduction used in the upstream processes. Commercial 
resin-based anion-exchangers suffer from poor binding capacities for plasmid DNA due to 
small pore sizes (< 30 nm in diameter), and were initially designed and optimized for the 
purification of proteins, which exclude pDNA (with a typical hydrodynamic radius around 
150-250 nm) from entering the inner pores of resins. Therefore, high capacity adsorbents 
with convective “superpores” are being developed for the efficient purification of plasmid 
DNA9-12. Several RNase-free bioprocesses based on anion-exchange chromatography have 
consequently been developed13, however, they are rather complex and time-consuming, and 
need an additional operational unit to accommodate the resulting burden of RNA impurity14. 
Alternatives to packed-bed chromatography have been developed in the last 15 years, and 
include now a variety of approached that include, but is not limited to functionalized 
“monolithic” rods3, 6, 15-18, (composite) synthetic membranes19, 20 and (magnetic) micro-to-
nano particles21. All the mentioned systems present comparative advantages and 
disadvantages. Some techniques are applicable to specific “niches” in the purification of 
bioproducts. There is room enough for additional developments in the field.  
“Expanded” material backbones can be efficiently functionalized to bind a whole 
range of bioproducts. Larger voidage pores within the structure of the mentioned materials, 
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derive in the absence of diffusive mass transport limitations22. Such expanded backbones can 
be manufactured methods like the cryogel-technique, that has been already explored for 
purification of pDNA . A second approach consists in the production of non-woven fibrous 
networks, where is active material is provided by the fibers themselves. In principle, such 
adsorbent systems could accommodate a particle-containing sample or feedstock, therefore 
facilitating the purification scheme. An additional advantage results from the lack of back-
pressure during operation. The purification or fractionation of nanoplexes and cells could also 
be envisioned with such systems. Along this line of thought, the megaporous structure of 
expanded adsorbent should allow the penetration of large pDNA molecules at high flow rate 
with low-pressure drops . 
Gene therapy involves the transfer of a therapeutic gene into a patient with the 
objective of either curing a disease or reducing the spread of illness . The effectiveness of 
gene therapy is based on the vector capable of transferring the therapeutic gene into the target 
cells. Naked or plasmid DNA vectors are increasingly utilized over the viral vectors as the 
virus based vectors pose safety and regulatory concerns over their usage for gene therapy . 
Consequently, there has been a demand for using pDNA as the vector for delivering the 
therapeutic genes in gene therapy and DNA vaccination. Plasmid DNA vectors have several 
technical advantages over other conventional vectors, such as low production cost, high 
product stability, and safety .  Plasmids are extra-chromosomal double-stranded circular 
DNA molecules found in virtually all bacterial species and can replicate autonomously. They 
have sizes up to hundreds of kilobasepairs (kb) and are found in three forms, namely, 
supercoiled (SC), open circular (OC) and linear (L) . For large-scale production of pDNA, the 
therapeutic gene is inserted into the appropriate vector and then introduced into a microbial 
host, most commonly E. coli. 
In the present study, we have evaluated the efficacy of anion-exchange (composite) expanded 
adsorbents to purify pDNA . These adsorbents consist of either non-woven cellulosic fibers 
or cryogel-type backbones, which were first graft-polymerized with GMA , and subsequently 
modified via free epoxy groups to have DEAE functionality, where the nitrogen content of 
the resulting DEAE adsorbents was evaluated using elemental analysis. These adsorbents 
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could potentially be integrated with RNase-free downstream bioprocesses for addressing the 
issues of low capacity, reduced resolution from host impurities (e.g. gDNA and high 
molecular weight RNA), as well as the  high complexity of the overall purification process. 
For this specific application, the high viscosities of DNA extracts and the low diffusivity 
characteristic of larger macromolecules introduce severe performance limitations. 
 
 
 
Material and methods 
Chemicals and reagents 
Sodium chloride (NaCl), sodium hydroxide (NaOH), ethylenediaminetetraacetic acid 
(EDTA), and ethidium bromide solution 1% were purchased from AppliChem GmbH 
(Darmstadt, Germany). Tris (99.3%, buffer grade) was purchased from Carl Roth (Karlsruhe, 
Germany). Buffer P1 “Resuspension Buffer”, Buffer P2 “Lysis Buffer”, and Buffer P3 
“Neutralization Buffer” were purchased from Qiagen (Hilden, Germany). Ethanol absolute 
was obtained from Honeywell Specialty chemicals Seelze GmbH (Seelze, Germany). 
All the buffer solutions were filtered through 0.45 µm disposable membrane filters 
(Sartorius, Goettingen, Germany). 
 
Bacterial culture 
E. coli DH5± strain containing a pTurbo GFP plasmid of 4.7 kb length was 
generously provided by Generi Biotech (Hradec Králové 11, Czech Republic). The culture 
was harvested by centrifugation and stored at -20 °C until further use. 
The bacterial strain was propagated in TB enriched medium (glycerol 13 g/L, 
vitamins, yeast extract 24 g/L, triptone 12 g/L, KH2PO4 2.31 g/L, K2HPO4 12.54 g/L). The 
inoculum was grown in 0.5 L Erlenmeyer flasks containing 100 mL of TB-enriched medium. 
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The culture developed in shaking flasks (240 rpm) at 37 °C. The cultures were harvested 
during the stationary phase. Biomass was followed by turbidimetry (600 nm). The cell 
biomass (20 – 24 g/L wet weight) was harvested by centrifugation and disrupted utilizing a 
conventional alkaline lysis protocol (see below). 
 
Cell lysis  
Bacteria were lysed using a modification of the alkaline method described previously. 
Bacterial Cell Lysate (20 g) was re-suspended in 200 mL of Buffer P1 (50 mM Tris buffer 
pH 8.0 containing 10 mM EDTA) and then treated with 200 mL cell lysis buffer P2 (0.2 M 
NaOH and 1% SDS) for 30 min at 4 °C. The lysate mixture was neutralized with 200 mL 
buffer P3 (3 M potassium acetate, adjusted to pH 5.0 with glacial acetic acid and chilled to 4 
°C). All the precipitated materials including cell debris, most chromosomal DNA and some 
RNA and proteins were removed by centrifugation at 9000 x g for 10 min on a Sorvall RC5C 
Plus (Kendro, Newton, CT) and followed by clarification through a 0.45 µm Sartobran P 
Filter. A clarified lysate containing pDNA concentration in the range of 24 to 47 µg per mL 
was obtained; the amount of pDNA was evaluated using a purification commercial kit 
(QIAGEN, Hilden, Germany) followed by spectrophotometry ((NanoDrop, Wilmington, 
DE). Before chromatography, the clarified lysate was dialyzed overnight against 10 mM 
Tris–HCl buffer (pH 8.0) or diluted in the mentioned buffer; this has adjusted the 
conductivity value of the feedstock (≈ 15-20 mS/cm). 
 
Preparative chromatography 
The CG-DEAE-fibers and GIR-DEAE Cryogels were sythesized as previously 
reported9, 16, 23. They were packed in 5.5 cm × 5 mm and 3.4 cm × 10 mm columns, 
respectively (GE Amersham Biosciences, Uppsala, Sweden) and connected to a Äkta 
Explorer 100 having UNICORN™ 4.10 software (GE Amersham Biosciences, Uppsala, 
Sweden). The equilibration of AEX adsorbents was carried out with 50 mM Tris, 10 mM 
EDTA, 200 mM NaCl, pH 7.2 at a flow rate of 300 cm/h. 200 (GIR-DEAE Cryogel)/400 mL 
(CG-DEAE fibers) clarified lysate of pTurbo GFP plasmid diluted in equilibration buffer 
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(1:10) was loaded onto AEX columns at 300 cm/h. The bound species were eluted with a 
buffer containing 20 mM Tris, 10 mM EDTA, 1 M NaCl at pH 7.2 in a linear gradient (20/30 
CV). All the fractions collected during chromatography were pooled according to the 
chromatograms and were further analyzed using the NanoDrop procedure and / or and 
agarose gel electrophoresis (see below). The amount of plasmid DNA bound was determined 
using the 50% breakthrough volume (V), column void volume (V0), initial pDNA 
concentration (C0), and the column volume (CV), as shown in Equation 1. 
CV
)V(VC
(mg/mL)  DBC 00
−×
=                     (1) 
A measure of the ion-exchange capacity of adsorbents was obtained using transient 
pH measurements24. Utilising this method, ionic capacities of 403 mmol/L and 119 mmol/L 
were measured for CG-DEAE fibers and GIR-DEAE Cryogel, respectively. 
 
 
DNA/RNA concentration determination and agarose gel electrophoresis 
All the pDNA loads and pooled fraction concentrations were determined using the 
NanoDrop 2000 procedure mentioned before. One OD unit at 260 nm in a 10 mm cuvette 
was assumed to correspond to a concentration of 50 µg/mL of dsDNA. The pDNA load and 
the fractions collected after chromatography were additionally analyzed using 0.8% agarose 
gel electrophoresis in TAE (40 mM Tris, 20 mM acetic acid, 1 mM EDTA, pH 8.0). A 1 kb 
Plus DNA ladder was used as a marker. The electrophoresis was carried out at 80 V for 1 
hour and then stained with ethidium bromide for 30 min. 
 
Results and discussion 
Large scale purification of pharmaceutical-grade pDNA is generally based on the 
adsorption capacity and reversibility, where two limitations need to be overcome. Firstly, 
large biomolecules, like pDNA, possess low diffusion coefficients and display slow binding 
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kinetics22. Hence, it is advantageous to use convective media for their purification. Secondly, 
they need large pores with high interconnectivity such that molecules can penetrate easily 
into the interior part of the bead structure. Monoliths and membranes are the best options to 
overcome these limitations. In contrast to conventional media, monoliths have a continuous 
porous structure with a convective flow regime of the mobile phase. Furthermore, the large 
pore diameters of the monolithic column allow for better mass transfer in the case of larger 
bioparticles16, 24. 
The production of novel chromatography adsorbents is an ever-evolving field. The 
advances in cell and life sciences produce an expanding variety of biotechnolgy-derived 
products. And ont every product can be easily hadled with existing purification platforms. In 
this context, research has been gered towards a) the development of new or improved 
adsorbents (to expand applications to emerging product niches) and b) the development of 
new processing schemes (to extend the life cycle of existing adsorbents). In the specific case 
of pDNA, initial attempts to purify such product with existing (and diffusion controlled) 
beaded adsorbents were unsecsesfull.  However, initial studies found that binding of pDNA 
was pellicular in nature; very large macromolecules are excluded from traditional 
chromatography beads. Nowadys, convective-flow commercial adsorbents exist (CIM / BIA, 
Ajdova� ina, Slovenia). Since these systems offer limited scale-up capabilities, industrial users 
take advantage of the high capacity of beaded adsorbents (CaptoAdhere / GE, Uppsala, 
Sweden) and utilized them in the “negative” mode (i.e. impurities are trapped by the 
adsorbent while the product is found in the flow-through).  
In the mentioned context, we have evaluated materials other than the ones mentioned 
above; these are well known in the market. In our approach, a NW fiber network, as well as, 
a cryogel-type backbone were modified to harbor epoxide functionality. This was performed 
by grafting with a single vinyl-containing monomer such as GMA and two modes of 
initiators, physical and chemical. Finally, pendant epoxy groups were modified to provide 
weak anion-exchange functionality9, 23. The (dynamic) binding capacity of the composite 
anion exchange, high voidage, adsorptive systems was investigated for pDNA purification. In 
this work, the use of RNase for reducing RNA impurities was avoided as they further 
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complicate the purification process by adding an additional step for the removal of RNase 
from the plasmid extract. 
Reversible binding of pDNA (generated from E. coli cells) onto grafted adsorbents 
was determined by eluting the adsorbed pDNA with a linear gradient elution using 20 mM 
Tris-HCl buffer containing 2.0 M sodium chloride. Plasmid DNA capacity was determined 
by quantifying the amount bound to the adsorbents according to Equation 1. The 
chromatographic purification was performed using 20 mM Tris-HCl, 10 mM EDTA, pH 7.4, 
where pDNA load conductivity was adjusted using equilibration to 25-28 mS/cm, and the 
bound pDNA was eluted using 1.0 M sodium chloride in 20 mM Tris-HCl. The dynamic 
binding capacity (from eluted fractions) for CG-DEAE-NW (fibrous) and GIR-DEAE-MP 
(cryogel-type) was 2.4 mg/mL and 1.3 mg/mL, respectively. The chromatographic profiles 
for different adsorbents can be observed in Figure 1a and 1b. From the agarose gel 
electrophoresis (Figure 2a and 2b) it is clear that RNA is co-eluted with pDNA, which may 
contribute the low pDNA binding capacities. This effect could be alleviated by a “negative” 
chromatography capture of small contaminants (e.g. RNA) immediately upstream -which can 
be based on traditional (beads) or alternative (fibrous) adsorbents. 
Our preparation depicts an abundant presence of RNA in the crude pDNA load. As 
mentioned, removal of RNA impurities from the pDNA presents a genuine challenge in the 
production of gene therapy products. In the case of fibrous adsorbents, a low capacity for 
pDNA could result from a combination of competition and exclusion effects. pDNA 
preferentially bind to the internal surface of the megaporous structure. And internal surface 
is, in turn limited by geometrical considerations. It is interesting to note that the same 
adsorbents showed a very reasonable capacity for model proteins (for example, BSA) 
indicating that functionaly is present. In a nutshell, pDNA capacity values (50% 
breakthoruth) were in the reange of 1.20 mg / mL to 2.50 mg / mL). This is higher (Table 1) 
than the capacity observed in commercial Q and DEAE Sepharose FF resins. However, 
composite adsorbents showed lower capacities when compared to the CIM-DEAE monoliths, 
which have been extensively used for the large-scale purification of pDNA25. 
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These experiments indicate that “expanded” adsorbents of the type studied in this 
work still present a significant binding capacity for pDNA having a molecular weight >1750 
kDa; these data add to our knowledge on this completely new class chromatography 
modality. All in all, composite adsorbents could be further developed to serve the purpose of 
primary, intermediate or late-stage purification.  
 
 
Conclusions 
In this study, we have evaluated the performance of DEAE-based composite 
adsorbents in relation to their ability to reversely capture (and purify) a large macromolecular 
entity (sc pDNA). The performance of the expanded DEAE system was assessed by 
saturating the “column” with a clarified lysate solution. The product were eluted by 
increasing the salt concentration. These anion-exchange adsorbents showed promising 
binding capacity at moderate-high flow rates.  A less desirable feature observed of the new 
anion exchange was a limited capacity when compared to benchmark commercial products. 
For excluded macromolecules there is an obvious compromise between internal surface are 
and the total degree of porosity within the material. Further studies are needed to explore 
other types of composites and to understand the performance limits of this type of materials. 
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Figure captions 
 
Figure 1. a) pDNA capture onto CG-DEAE fibers at 300 cm/h. Conditions: Stationary phase: 
1 mL of column volume; Load: 400 mL pDNA (100 µg/mL); equilibration buffer: 50 mM 
Tris-HCl, 10 mM EDTA, 300 mM NaCl, pH 7.4; washing buffer – 50 mM Tris-HCl, 10 mM 
EDTA, pH 7.4; elution buffer – 50 mM Tris-HCl, 10 mM EDTA, 1 M NaCl, pH 7.4; flow 
rate: 1 mL/min; UV detection at 260 and 280 nm. b) pDNA capture onto GIR-DEAE cryogels 
at 300 cm/h. Conditions: Stationary phase: 2.7 mL of column volume; Load: 200 mL pDNA 
(100 µg/mL); equilibration buffer: 50 mM Tris-HCl, 10 mM EDTA, 300 mM NaCl, pH 7.4; 
washing buffer – 50 mM Tris-HCl, 10 mM EDTA, pH 7.4; elution buffer – 50 mM Tris-HCl, 
10 mM EDTA, 1 M NaCl, pH 7.4; flow rate: 4 mL/min; UV detection at 260 and 280 nm. 
Figure 2. Agarose gel electrophoresis of pDNA captured using grafted adsorbents. (a) CG-
DEAE fibers; Lane M shows DNA Ladder, Lane L shows pDNA load, Lane LFT shows load 
flow through, Lane WFT shows wash flow through, Lane P1 (2 fractions)–P2 (2 fractions) 
shows elution profiles. (b) GIR-DEAE cryogels; Lane M shows DNA Ladder, Lane L shows 
pDNA load, Lane LFT shows load flow through, Lane WFT shows wash flow through, Lane 
P1–P4 shows elution profiles. 
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Tables with Captions 
Table 1: Comparison of dynamic binding capacities of CG and GIR.  
Adsorbents Capacity  
(mg/mL) 
CG-DEAE fibers 2.4 
GIR-DEAE cryogels 1.3 
DEAE Sepharose FF [59] 0.26 
Toyopearl DEAE 650 M [59] 0.39 
Q Sepharose FF [60] 0.72 
Fratogel-DEAE [60]  2.45 
Q Ceramic HyperD 20 [59, 60] >2.5 
CIM-DEAE [61] 6 - 8 
   CG stands for chemical grafting; GIR is gamma irradiation; Flow rate – 300 cm/h. 
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